BELGIUM - Capital-E backs EUR 1.11m CMOSIS funding
Capital-E portfolio company CMOSIS has raised just over EUR 1m in a series-B financing round subscribed to by existing shareholders and management.
More on Early-stage
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018
Swanlaab leads $8m series-A round for Landbot
Startup has so far raised $10.2m in funding since being founded in 2017
Forbion et al. in $196m round for NewAmsterdam Pharma
Company intends to use the fresh capital to finance the full phase-III development of its obicetrapib drug
Latest News
Sagard buys Nutrisens from Evolem, Unigrains
Nutrisens management team, led by CEO Georges Devesa, retains a significant stake in the company
Litorina-backed Fractal Gaming Group to list
Intention to list comes four years after the GP acquired the company via its fourth fund
VC-backed Mister Spex buys Tribe
Online optician has previously received VC funding from investors including Grazia Equity and Goldman Sachs
Moonfare, Lexington launch digital secondaries platform
Platform will enable smaller investors to put their secondaries stakes up for sale